Virtue Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $721K | Buy |
6,104
+1,202
| +25% | +$139K | 0.11% | 162 |
|
|
2025
Q4 | $522K | Sell |
4,902
-18,800
| -79% | -$1.76M | 0.08% | 161 |
|
|
2025
Q3 | $12.3M | Buy |
23,702
+20,437
| +626% | +$1.68M | 1.96% | 12 |
|
|
2025
Q2 | $258K | Sell |
3,265
-1,745
| -35% | -$139K | 0.05% | 220 |
|
|
2025
Q1 | $450K | Sell |
5,010
-2,199
| -31% | -$205K | 0.05% | 281 |
|
|
2024
Q4 | $717K | Sell |
7,209
-1,542
| -18% | -$159K | 0.14% | 109 |
|
|
2024
Q3 | $994K | Sell |
8,751
-240
| -3% | -$28.5K | 0.2% | 79 |
|
|
2024
Q2 | $1.12M | Sell |
8,991
-631
| -7% | -$81.3K | 0.19% | 90 |
|
|
2024
Q1 | $1.21M | Buy |
9,622
+560
| +6% | +$69K | 0.22% | 86 |
|
|
2023
Q4 | $1.06M | Sell |
9,062
-10,245
| -53% | -$1.06M | 0.21% | 88 |
|
|
2023
Q3 | $2.2M | Hold |
19,307
| – | – | 0.37% | 51 |
|
|
2023
Q2 | $2.2M | Buy |
19,307
+1,434
| +8% | +$163K | 0.37% | 51 |
|
|
2023
Q1 | $2.03M | Buy |
17,873
+6,145
| +52% | +$663K | 0.33% | 47 |
|
|
2022
Q4 | $1.3M | Buy |
+11,728
| New | +$1.2M | 0.2% | 76 |
|
|
2022
Q3 | – | Sell |
-2,443
| Closed | -$223K | – | 289 |
|
|
2022
Q2 | $223K | Sell |
2,443
-10,169
| -81% | -$902K | 0.04% | 236 |
|
|
2022
Q1 | $1.03M | Buy |
12,612
+2,540
| +25% | +$200K | 0.16% | 159 |
|
|
2021
Q4 | $772K | Buy |
10,072
+2,715
| +37% | +$216K | 0.11% | 209 |
|
|
2021
Q3 | $553K | Sell |
7,357
-391
| -5% | -$29.7K | 0.1% | 230 |
|
|
2021
Q2 | $603K | Sell |
7,748
-1,889
| -20% | -$141K | 0.12% | 207 |
|
|
2021
Q1 | $709K | Sell |
9,637
-242
| -2% | -$17.9K | 0.17% | 172 |
|
|
2020
Q4 | $771K | Sell |
9,879
-4,031
| -29% | -$308K | 0.19% | 150 |
|
|
2020
Q3 | $1.1M | Sell |
13,910
-5,704
| -29% | -$447K | 0.27% | 110 |
|
|
2020
Q2 | $1.45M | Buy |
+19,614
| New | +$1.48M | 0.33% | 90 |
|
|
2020
Q1 | – | Sell |
-10,405
| Closed | -$903K | – | 149 |
|
|
2019
Q4 | $903K | Sell |
10,405
-5,072
| -33% | -$417K | 0.26% | 79 |
|
|
2019
Q3 | $1.24M | Sell |
15,477
-659
| -4% | -$52.8K | 0.41% | 82 |
|
|
2019
Q2 | $1.29M | Buy |
16,136
+13,602
| +537% | +$1.04M | 0.47% | 66 |
|
|
2019
Q1 | $201K | Sell |
2,534
-268
| -10% | -$20K | 0.07% | 108 |
|
|
2018
Q4 | $204K | Sell |
2,802
-44,551
| -94% | -$3.14M | 0.1% | 80 |
|
|
2018
Q3 | $3.21M | Buy |
47,353
+26,525
| +127% | +$1.69M | 0.68% | 47 |
|
|
2018
Q2 | $1.21M | Sell |
20,828
-572
| -3% | -$32.3K | 0.59% | 50 |
|
|
2018
Q1 | $1.23M | Buy |
+21,400
| New | +$1.16M | 0.65% | 22 |
|
Other funds holding MRK
VCM
VPM
Virtue Capital Management's MRK Position: Q1 2026 in Review
Virtue Capital Management increased its Merck (MRK) stake by 25% in Q1 2026, buying an estimated $139K and bringing the position to 6,104 shares worth $721K. The position accounts for 0.11% of the portfolio, ranked #162.
Virtue Capital Management first reported a position in MRK in Q1 2018 and has held it in 31 quarters since. The position peaked at $12.3M in Q3 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Virtue Capital Management held 6,104 shares of Merck worth $721K as of Q1 2026.
- Virtue Capital Management bought 1,202 Merck shares in Q1 2026, an estimated $139K.
- Merck made up 0.11% of Virtue Capital Management's portfolio in Q1 2026, its #162 holding.
- Virtue Capital Management first reported a position in Merck in Q1 2018 and has held it in 31 quarters since.
- Virtue Capital Management's Merck position peaked at $12.3M in Q3 2025.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Virtue Capital Management's 13F filing for Q1 2026, filed 7 May 2026.